Article
A New Approach to the Inhibition of Metallo‐β‐lactamases
11 Jan 2006
Abstract excerpt
Plan of attack: β-Lactam antibiotics remain at the forefront of the battle with pathogenic bacteria, particularly of Gram-negative strains that cause hospital-acquired infections. Metallo-β-lactamases, enzymes that confer resistance to almost all β-lactams, are spreading in these organisms. A new class of irreversible metallo-β-lactamase inhibitor (OPS; see picture) offers hope for the development of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
